E-LIB Suche - Ergebnisse für: Kahle, Michael P

1

Convergent MAPK pathway alterations mediate acquired resist..:

DiPeri, Timothy P. ; Zhao, Ming ; Evans, Kurt W....
Journal of Hepatology. 80 (2024) 2 - p. 322-334 , 2024

Link: https://doi.org/10.1016/..

2

Perlecan Domain-V Enhances Neurogenic Brain Repair After St..:

Trout, Amanda L. ; Kahle, Michael P. ; Roberts, Jill M....
Translational Stroke Research. 12 (2020) 1 - p. 72-86 , 2020

Link: https://doi.org/10.1007/..

3

Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto..:

Kahle, Michael P. ; Cuevas, Bruce D.
Journal of Molecular Signaling. 10 (2015) - p. , 2015

Link: https://doi.org/10.5334/..

4

MEKK2 regulates focal adhesion stability and motility in in..:

Mirza, Ahmed A. ; Kahle, Michael P. ; Ameka, Magdalene..
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843 (2014) 5 - p. 945-954 , 2014

Link: https://doi.org/10.1016/..

5

Neuronal Restoration Following Ischemic Stroke: Influences,..:

Kahle, Michael P. ; Bix, Gregory J.
Neurorehabilitation and Neural Repair. 27 (2013) 5 - p. 469-478 , 2013

Link: https://doi.org/10.1177/..

6

Successfully Climbing the "STAIRs": Surmounting Failed Tran..:

Kahle, Michael P. ; Bix, Gregory J.
Stroke Research and Treatment. 2012 (2012) - p. 1-8 , 2012

Link: https://doi.org/10.1155/..

7

Perlecan domain V is upregulated in human brain arterioveno..:

Kahle, Michael P. ; Lee, Boyeon ; Pourmohamad, Tony...
NeuroReport. 23 (2012) 10 - p. 627-630 , 2012

Link: https://doi.org/10.1097/..

8

Perlecan domain V is upregulated in human brain arterioveno..:

Kahle, Michael P. ; Lee, Boyeon ; Pourmohamad, Tony...
NeuroReport. 23 (2012) 10 - p. 627-630 , 2012

Link: https://doi.org/10.1097/..

9

Perlecan and the Blood-Brain Barrier: Beneficial Proteolysi..:

Roberts, Jill ; Kahle, Michael P. ; Bix, Gregory J.
Frontiers in Pharmacology. 3 (2012) - p. , 2012

Link: https://doi.org/10.3389/..

10

Perlecan Domain-V Enhances Neurogenic Brain Repair After St..:

Trout, Amanda L ; Kahle, Michael P ; Roberts, Jill M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803718/. , 2020

Link: http://www.ncbi.nlm.nih...

11

Identification of Actionable Genomic Alterations Using Circ..:

Sánchez, Nora S ; Kahle, Michael P ; Bailey, Ann Marie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448805/. , 2019

Link: http://www.ncbi.nlm.nih...

12

CXCR7 Reactivates ERK Signaling to Promote Resistance to EG..:

Becker, Jeffrey H ; Gao, Yandi ; Soucheray, Margaret...
qt1kz2f818. , 2019

Link: https://escholarship.org..

13

CXCR7 reactivates ERK signaling to promote resistance to EG..:

Becker, Jeffrey H ; Gao, Yandi ; Soucheray, Margaret...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746175/. , 2019

Link: http://www.ncbi.nlm.nih...

14

Interaction with the Paxillin LD1 Motif Relieves MEKK2 Auto..:

Kahle, Michael P ; Cuevas, Bruce D
https://account.jmolecularsignaling.com/index.php/up-j-jms/article/view/1750-2187-10-4/258. , 2015

Link: https://account.jmolecul..

15

MEKK2 Regulates Paxillin Ubiquitylation and Localization in..:

Ameka, Magdalene ; Kahle, Michael P ; Perez-Neut, Mathew...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467534/. , 2014

Link: http://www.ncbi.nlm.nih...